Phenylacetylindole: Difference between revisions
Appearance
Content deleted Content added
Importing Wikidata short description: "Class of cannabinoid designer drugs" (Shortdesc helper) |
m →top: Task 17 (BRFA trial): replace to-be-deprecated: |name-list-format= (1× replaced; usage: 1 of 1); |
||
Line 1: | Line 1: | ||
{{short description|Class of cannabinoid designer drugs}} |
{{short description|Class of cannabinoid designer drugs}} |
||
[[File:JWH-167.svg|thumb|right|upright|Chemical structure of [[JWH-167]], a simple phenylacetylindole]] |
[[File:JWH-167.svg|thumb|right|upright|Chemical structure of [[JWH-167]], a simple phenylacetylindole]] |
||
'''Phenylacetylindoles''' are a class of [[synthetic cannabinoids]].<ref>{{cite journal | last1 = Manera | first1 = C | last2 = Tuccinardi | first2 = T | last3 = Martinelli | first3 = A | title = Indoles and related compounds as cannabinoid ligands | journal = Mini Reviews in Medicinal Chemistry | volume = 8 | issue = 4 | pages = 370–87 | year = 2008 | pmid = 18473928 |name-list- |
'''Phenylacetylindoles''' are a class of [[synthetic cannabinoids]].<ref>{{cite journal | last1 = Manera | first1 = C | last2 = Tuccinardi | first2 = T | last3 = Martinelli | first3 = A | title = Indoles and related compounds as cannabinoid ligands | journal = Mini Reviews in Medicinal Chemistry | volume = 8 | issue = 4 | pages = 370–87 | year = 2008 | pmid = 18473928 |name-list-style=vanc | doi=10.2174/138955708783955935}}</ref> |
||
In the United States, all CB<sub>1</sub> receptor agonists of the 3-phenylacetylindole class are [[Schedule I Controlled Substance]]s.<ref>{{UnitedStatesCode2|21|812|Schedules of controlled substances}}</ref> |
In the United States, all CB<sub>1</sub> receptor agonists of the 3-phenylacetylindole class are [[Schedule I Controlled Substance]]s.<ref>{{UnitedStatesCode2|21|812|Schedules of controlled substances}}</ref> |
Latest revision as of 06:14, 20 October 2020
Phenylacetylindoles are a class of synthetic cannabinoids.[1]
In the United States, all CB1 receptor agonists of the 3-phenylacetylindole class are Schedule I Controlled Substances.[2]